Paramasivam Arumugam (Arumugam Paramasivam)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 19

Top Venues

Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology

Centre for Cellular and Molecular Biology CSIR

UNIVERSITY OF MADRAS (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Centre for Cellular and Molecular Biology CSIR Sep 01 2016 - Aug 31 2018

India

POST DOCTORAL RESEARCH FELLOW :: GENETICS

Centre for Cellular and Molecular Biology CSIR Jun 01 2013 - Aug 31 2016

India

RESEARCH ASSOCIATE :: GENETICS

Education History

UNIVERSITY OF MADRAS Jun 15 2008 - Jan 27 2014

India

PHD :: DEPARTMENT OF GENETICS

University of Madras - Taramani Campus Jun 15 2005 - Apr 15 2007

India

MSC :: GENETICS

University of Madras - Taramani Campus Jun 15 2002 - Jun 15 2004

India

BSC :: MICROBIOLOGY

Publications

Priyadharshini Muthumanickam, Abilasha Ramasubramanian, Chandra Pandi, Balachander Kannan, Anitha Pandi, Pratibha Ramani, Vijayashree Priyadharsini Jayaseelan, Paramasivam Arumugam
The novel m6A writer methyltransferase 5 is a promising prognostic biomarker and associated with immune cell infiltration in oral squamous cell carcinoma. Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 53 (8) (2024)
Dodla Rukmini, Balachander Kannan, Chandra Pandi, Anitha Pandi, Prathibha Prasad, Vijayashree Priyadharsini Jayaseelan, Paramasivam Arumugam
Aberrated PSMA1 expression associated with clinicopathological features and prognosis in oral squamous cell carcinoma. Odontology 112 (3) (2024)
Jonah Justin David, Balachander Kannan, Chandra Pandi, Vijayashree Priyadharsini Jayaseelan, Jeevitha Manicka Vasagam, Paramasivam Arumugam
Increased SEC14L2 expression is associated with clinicopathological features and worse prognosis in oral squamous cell carcinoma. Odontology (2024)
Dodla Rukmini, Balachander Kannan, Chandra Pandi, Anitha Pandi, Prathibha Prasad, Vijayashree Priyadharsini Jayaseelan, Paramasivam Arumugam
Aberrated PSMA1 expression associated with clinicopathological features and prognosis in oral squamous cell carcinoma. Odontology (2024)
Priyadharshini Muthumanickam, Abilasha Ramasubramanian, Chandra Pandi, Balachander Kannan, Anitha Pandi, Pratibha Ramani, Vijayashree Priyadharsini Jayaseelan, Paramasivam Arumugam
The novel m6A writer methyltransferase 5 is a promising prognostic biomarker and associated with immune cell infiltration in oral squamous cell carcinoma. Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology (2024)
Abilasha Ramasubramanian, Pratibha Ramani, Balachander Kannan, Paramasivam Arumugam
High expression of novel biomarker TBRG4 promotes the progression and invasion of oral squamous cell carcinoma. Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology (2023)
Vijayashree Priyadharsini Jayaseelan, Paramasivam Arumugam
Post-transcriptional gene silencing by nucleic acid gapmers: a promising therapeutic modality for cancer. Epigenomics (2023)
Vijayashree Priyadharsini Jayaseelan, Loganathan Kavitha, Anitha Pandi, Abilasha Ramasubramanian, Balachander Kannan, Paramasivam Arumugam
Proteolysis-targeting chimeras targeting epigenetic modulators: a promising strategy for oral cancer therapy. Epigenomics (2023)
Vijayashree Priyadharsini Jayaseelan, Paramasivam Arumugam
Exosomal microRNAs Targeting TP53 Gene as Promising Prognostic Markers for Head and Neck Squamous Cell Carcinoma. Global medical genetics 9 (4) (2022)
Vijayashree Priyadharsini Jayaseelan, Paramasivam Arumugam
Epigenetic modulator LSD1, a theragnostic target for potentially malignant oral disorders and malignant lesions. Epigenomics 14 (20) (2022)
Paramasivam Arumugam, Vijayashree Priyadharsini Jayaseelan
The emerging role of m6A modification in autophagy regulation and its implications in human disease. Epigenomics 14 (10) (2022)
Vijayashree Priyadharsini Jayaseelan, Paramasivam Arumugam
Exosome engineering: a promising step toward cancer therapeutics. Epigenomics 14 (9) (2022)
Vijayashree Priyadharsini Jayaseelan, Paramasivam Arumugam
A Computational Data Mining Strategy to Identify the Common Genetic Markers of Temporomandibular Joint Disorders and Osteoarthritis. Global medical genetics 9 (2) (2022)
Vijayashree Priyadharsini Jayaseelan, Paramasivam Arumugam
Exosomal microRNAs Targeting TP53 Gene as Promising Prognostic Markers for Head and Neck Squamous Cell Carcinoma. Global medical genetics 9 (4) (2022)
Paramasivam Arumugam, Jayaseelan Vijayashree Priyadharsini
RNA N6-methyladenosine: a new player in autophagy-mediated anti-cancer drug resistance. British journal of cancer 124 (10) (2021)
Paramasivam Arumugam, Vijayashree Priyadharsini Jayaseelan
Implication of epitranscriptomics in trained innate immunity and COVID-19. Epigenomics 13 (14) (2021)
Vijayashree Priyadharsini Jayaseelan, Paramasivam Arumugam
RNA editors: key regulators of viral response in cancer patients. Epigenomics 13 (3) (2021)
Vijayashree Priyadharsini Jayaseelan, Paramasivam Arumugam
Exosome-derived ncRNAs as potential drivers of epigenetic reprogramming of cancer stem cells. Epigenomics 13 (18) (2021)
Paramasivam Arumugam, Vijayashree Priyadharsini Jayaseelan
Epigenetic modifications of RNA and their implications in antiviral immunity. Epigenomics 12 (19) (2020)

Paramasivam Arumugam.css-eqlu8i{font-size:small;padding-left:4px;} (Arumugam Paramasivam)

Publication Activity (10 Years)

Top Topics

Top Venues

Paramasivam Arumugam (Arumugam Paramasivam)